Summit Trail Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
22,579
+2,127
+10% +$156K 0.02% 789
2026
Q1
$1.56M Buy
20,452
+7,605
+59% +$548K 0.02% 699
2025
Q4
$829K Buy
12,847
+8,206
+177% +$506K 0.01% 904
2025
Q3
$296K Sell
4,641
-19,244
-81% -$1.34M ﹤0.01% 1211
2025
Q2
$1.8M Buy
+23,885
New +$1.88M 0.03% 292
2018
Q1
Sell
-1,192
Closed -$115K 794
2017
Q4
$115K Buy
+1,192
New +$108K 0.01% 585

Other funds holding EMN

Summit Trail Advisors's EMN Position: Q2 2026 in Review

Summit Trail Advisors increased its Eastman Chemical (EMN) stake by 10% in Q2 2026, buying an estimated $156K and bringing the position to 22,579 shares worth $1.51M. The position accounts for 0.02% of the portfolio, ranked #789.

Summit Trail Advisors first reported a position in EMN in Q4 2017 and has held it in 6 quarters since. The position peaked at $1.8M in Q2 2025. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Summit Trail Advisors held 22,579 shares of Eastman Chemical worth $1.51M as of Q2 2026.
  • Summit Trail Advisors bought 2,127 Eastman Chemical shares in Q2 2026, an estimated $156K.
  • Eastman Chemical made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #789 holding.
  • Summit Trail Advisors first reported a position in Eastman Chemical in Q4 2017 and has held it in 6 quarters since.
  • Summit Trail Advisors's Eastman Chemical position peaked at $1.8M in Q2 2025.
  • 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.